Patent Assignment
Reel/Frame 059935/0304
Assignment of Assignor's Interest
Recorded: 2022-05-17
Pages: 3
Assignor
YEDNOCK, THEODORE A.
Executed: 2007-05-30
Assignee
ELAN PHARMACEUTICALS, INC.
800 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, 94080
Covered Properties
(3)
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
Application:
17/745,409 →
Publication:
US 2023/0082238
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2013
From: ELAN PHARMACEUTICALS, INC.
To: BIOGEN IDEC INTERNATIONAL HOLDING LTD.
Reel/Frame 031214/0424 →
Assignment of Assignor's Interest
Sep 16, 2013
From: BIOGEN IDEC INTERNATIONAL HOLDING LTD.
To: BIOGEN IDEC MA INC.
Reel/Frame 031214/0500 →
Change of Name
May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Assignment of Assignor's Interest
May 17, 2022
From: ELAN PHARMACEUTICALS, INC.
To: BIOGEN IDEC INTERNATIONAL HOLDING LTD.
Reel/Frame 060092/0001 →
Assignment of Assignor's Interest
May 17, 2022
From: BIOGEN IDEC INTERNATIONAL HOLDING LTD.
To: BIOGEN IDEC MA INC.
Reel/Frame 060094/0426 →
Change of Name
May 17, 2022
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 060101/0440 →